Antimicrobial-Resistant Campylobacter Species from Retail Raw Meats
Open Access
- 1 May 2003
- journal article
- research article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 69 (5), 3005-3007
- https://doi.org/10.1128/aem.69.5.3005-3007.2003
Abstract
The antimicrobial susceptibilities of 378 Campylobacter isolates were determined. Resistance to tetracycline was the most common (82%), followed by resistance to doxycycline (77%), erythromycin (54%), nalidixic acid (41%), and ciprofloxacin (35%). Campylobacter coli displayed significantly higher rates of resistance to ciprofloxacin and erythromycin than Campylobacter jejuni, and Campylobacter isolates from turkey meat showed a greater resistance than those from chicken meat.Keywords
This publication has 22 references indexed in Scilit:
- CmeABC Functions as a Multidrug Efflux System in Campylobacter jejuniAntimicrobial Agents and Chemotherapy, 2002
- Morbidity of Infections Caused by Antimicrobial‐Resistant BacteriaClinical Infectious Diseases, 2002
- Prevalence ofCampylobacterspp., Escherichia coli, andSalmonellaSerovars in Retail Chicken, Turkey, Pork, and Beef from the Greater Washington, D.C., AreaApplied and Environmental Microbiology, 2001
- Rapid Pulsed-Field Gel Electrophoresis Protocol for Subtyping of Campylobacter jejuniJournal of Clinical Microbiology, 2001
- Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human IsolatesEmerging Infectious Diseases, 2001
- Characterization ofgyrAmutations associated with fluoroquinolone resistance inCampylobacter coliby DNA sequence analysis and MAMA PCRFEMS Microbiology Letters, 2000
- Food-Related Illness and Death in the United StatesEmerging Infectious Diseases, 1999
- Resistance inCampylobacterSpecies: Increased Resistance to Fluoroquinolones and Seasonal VariationClinical Infectious Diseases, 1999
- Quinolone-ResistantCampylobacter jejuniInfections in Minnesota, 1992–1998New England Journal of Medicine, 1999
- Evaluation of Sorivudine (BV‐araU) versus Acyclovir in the Treatment of Acute Localized Herpes Zoster in Human Immunodeficiency Virus‐Infected AdultsThe Journal of Infectious Diseases, 1997